<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3305">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01403805</url>
  </required_header>
  <id_info>
    <org_study_id>803121</org_study_id>
    <nct_id>NCT01403805</nct_id>
  </id_info>
  <brief_title>Effects of the Oral Care With Vaccines for Pneumonia in Elderly; Going Home Together Both Physician and Dentist</brief_title>
  <official_title>The Interventional Study in the Effects of Oral Care With Vaccines at Nursing Home; the Role of the Partnership With Physician, Dentist and Other Co-medical Stuff</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yubari Kibounomori</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Health Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Yubari Kibounomori</source>
  <oversight_info>
    <authority>Japan: Ministry of Health, Labor and Welfare</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective study comparing the effects of interventions (combined oral care and
      pneumococcal plus influenza vaccinations) in preventing pneumonia and increasing the
      survival rate from pneumonia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The elderly population can be expected to increase not only in developed countries, but also
      in developing countries. Pneumonia is one of the most common causes of death in the elderly.

      The investigators conducted a prospective study comparing the effects of interventions
      (combined oral care and pneumococcal plus influenza vaccinations) in preventing pneumonia
      and increasing the survival rate from pneumonia in consecutive elderly patients at a nursing
      home in Yubari during one year from 2009, with the results in a non-intervention group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Number of Participants With Pneumonia</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of Participants with Pneumonia sufferers</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death From Pneumonia</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of participants for the death from pneumonia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">199</enrollment>
  <condition>Pneumonia</condition>
  <arm_group>
    <arm_group_label>Oral care and vaccines</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral care and pneumococcal plus influenza vaccines</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vaccine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Influenza vaccine only</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Pneumococcal vaccination (Pneumovax NP, 21800AMY10131000)</intervention_name>
    <description>Injection,subcutaneous,0.5ml,ones,Planned duration of intervention:a day</description>
    <arm_group_label>Oral care and vaccines</arm_group_label>
    <other_name>Pneumovax NP</other_name>
    <other_name>Serial Number: 21800AMY10131000</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Influenza vaccination (Flubik HA, 16100EZZ01207000)</intervention_name>
    <description>Injection,subcutaneous,0.5ml,ones,Planned duration of intervention:a day</description>
    <arm_group_label>Oral care and vaccines</arm_group_label>
    <other_name>Flubik HA</other_name>
    <other_name>Serial Number: 16100EZZ01207000</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Influenza vaccination (Flubik HA, 16100EZZ01207000)</intervention_name>
    <description>Injection,subcutaneous,0.5ml,ones,Planned duration of intervention:a day</description>
    <arm_group_label>Vaccine</arm_group_label>
    <other_name>Flubik HA</other_name>
    <other_name>Serial Number: 16100EZZ01207000</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Specific frequency of oral care</intervention_name>
    <description>1 dentist and 2 dental hygienists visited the nursing home once a week. After the residents agreed our receive oral care, the dentist/dental hygienist spent 15 minutes with brushing of teeth, scaling, oral wiping, gargling and cleaning of dentures, to reduce dental plaque which is oral bacteria mechanically by using cleaning tools, including toothbrush, interdental brush, dental scaler, tongue brush, and sponge brush to treatment of periodontal disease at the washstand in their private room primary care physicians. At the same time, they taught and recorded to the nursing care workers the methods of administering responsible oral care to dye for dental plaque by using plaque disclosing agent material.</description>
    <arm_group_label>Oral care and vaccines</arm_group_label>
    <other_name>Not applicable:Behaviour</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The residents or an agent who understand the purpose of this study and give informed
             consent.

        Exclusion Criteria:

          -  The residents contraindicated to vaccine
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hirofumi Hashimoto, M.D.,Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Yubari Health Care Research Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Masahiro Hatta, D.D.S.</last_name>
    <role>Study Chair</role>
    <affiliation>Yubari Kibounomori</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Takahiro Ichiki, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Mukawa town National Health Insurance Hobetsu clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Katsushi Nagamori, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Yubari Health Care Research Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hiroyuki Morita, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yubari Health Care Research Cente</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Masako Hatta, D.D.S.</last_name>
    <role>Study Director</role>
    <affiliation>Yubari Health Care Research Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tomohiko Murakami, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Yubari Kibounomori</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yubari Kibounomori</name>
      <address>
        <city>Yubari</city>
        <state>Hokkaido</state>
        <zip>068-0402</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <lastchanged_date>April 29, 2012</lastchanged_date>
  <firstreceived_date>July 25, 2011</firstreceived_date>
  <firstreceived_results_date>August 2, 2011</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yubari Kibounomori</investigator_affiliation>
    <investigator_full_name>Masahiro Hatta</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Oral care</keyword>
  <keyword>Vaccine</keyword>
  <keyword>Pneumonia</keyword>
  <keyword>Elderly</keyword>
  <keyword>Prevention</keyword>
  <keyword>Primary care</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Influenza Vaccine</title>
          <description>Number of Participants with only an influenza vaccine(Flubik HA, 0.5ml, Mitsubishi Tanabe Pharm. Co.Ltd.).</description>
        </group>
        <group group_id="P2">
          <title>Oral Care With Influenza and Pneumococcal Vaccines</title>
          <description>Number of Participants with oral care and both an influenza vaccines (Flubik HA, 0.5ml, Mitsubishi Tanabe Pharm. Co.Ltd.) and a pneumococcal vaccine (PNEUMOVAX NP, 0.5ml, MSD Co.Ltd.) How to do oral care is the following;
1 dentist and 2 dental hygienists visited the nursing home once a week. After the residents agreed our receive oral care, the dentist/dental hygienist spent 15 minutes with brushing of teeth, scaling, oral wiping, gargling and cleaning of dentures, to reduce dental plaque which is oral bacteria mechanically by using cleaning tools, including toothbrush, interdental brush, dental scaler, tongue brush, and sponge brush to treatment of periodontal disease at the washstand in their private room. At the same time, we taught and recorded to the nursing care workers the methods of administering responsible oral care to dye for dental plaque by using plaque disclosing agent material.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="94"/>
                <participants group_id="P2" count="105"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Pneumonia Diagnosis</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="94"/>
                <participants group_id="P2" count="98"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Influenza Vaccine</title>
          <description>Number of Participants with only an influenza vaccine(Flubik HA, 0.5ml, Mitsubishi Tanabe Pharm. Co.Ltd.).</description>
        </group>
        <group group_id="B2">
          <title>Oral Care With Influenza and Pneumococcal Vaccines</title>
          <description>Number of Participants with oral care and both an influenza vaccines (Flubik HA, 0.5ml, Mitsubishi Tanabe Pharm. Co.Ltd.) and a pneumococcal vaccine (PNEUMOVAX NP, 0.5ml, MSD Co.Ltd.) How to do oral care is the following;
1 dentist and 2 dental hygienists visited the nursing home once a week. After the residents agreed our receive oral care, the dentist/dental hygienist spent 15 minutes with brushing of teeth, scaling, oral wiping, gargling and cleaning of dentures, to reduce dental plaque which is oral bacteria mechanically by using cleaning tools, including toothbrush, interdental brush, dental scaler, tongue brush, and sponge brush to treatment of periodontal disease at the washstand in their private room. At the same time, we taught and recorded to the nursing care workers the methods of administering responsible oral care to dye for dental plaque by using plaque disclosing agent material.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="94"/>
                <measurement group_id="B2" value="105"/>
                <measurement group_id="B3" value="199"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="2"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="2"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="92"/>
                <measurement group_id="B2" value="105"/>
                <measurement group_id="B3" value="197"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="85.0" spread="7.48"/>
                <measurement group_id="B2" value="86.0" spread="7.64"/>
                <measurement group_id="B3" value="85.5" spread="7.56"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="66"/>
                <measurement group_id="B2" value="77"/>
                <measurement group_id="B3" value="143"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="28"/>
                <measurement group_id="B2" value="28"/>
                <measurement group_id="B3" value="56"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Japan</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="94"/>
                <measurement group_id="B2" value="105"/>
                <measurement group_id="B3" value="199"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Pneumonia</title>
        <description>Number of Participants with Pneumonia sufferers</description>
        <time_frame>1 year</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Influenza Vaccine</title>
            <description>Number of Participants with only an influenza vaccine(Flubik HA, 0.5ml, Mitsubishi Tanabe Pharm. Co.Ltd.).</description>
          </group>
          <group group_id="O2">
            <title>Oral Care With Influenza and Pneumococcal Vaccines</title>
            <description>Number of Participants with oral care and both an influenza vaccines (Flubik HA, 0.5ml, Mitsubishi Tanabe Pharm. Co.Ltd.) and a pneumococcal vaccine (PNEUMOVAX NP, 0.5ml, MSD Co.Ltd.) How to do oral care is the following;
1 dentist and 2 dental hygienists visited the nursing home once a week. After the residents agreed our receive oral care, the dentist/dental hygienist spent 15 minutes with brushing of teeth, scaling, oral wiping, gargling and cleaning of dentures, to reduce dental plaque which is oral bacteria mechanically by using cleaning tools, including toothbrush, interdental brush, dental scaler, tongue brush, and sponge brush to treatment of periodontal disease at the washstand in their private room. At the same time, we taught and recorded to the nursing care workers the methods of administering responsible oral care to dye for dental plaque by using plaque disclosing agent material.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="94"/>
                  <measurement group_id="O2" value="105"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Number of Participants With Pneumonia</title>
            <description>Number of Participants with Pneumonia sufferers</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="21"/>
                  <measurement group_id="O2" value="2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The results were analyzed as means ± standard deviation (SD) or numbers (%). Differences between the 2 nursing homes were compared using Fisher’s test.</groups_desc>
            <non_inferiority>No</non_inferiority>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Fisher’s test 'Vaccine' versus 'Oral Care and Vaccines' and 'phumonia' and 'not pneumonia'</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Death From Pneumonia</title>
        <description>Number of participants for the death from pneumonia</description>
        <time_frame>1 year</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Influenza Vaccine</title>
            <description>Number of Participants with only an influenza vaccine(Flubik HA, 0.5ml, Mitsubishi Tanabe Pharm. Co.Ltd.).</description>
          </group>
          <group group_id="O2">
            <title>Oral Care With Influenza and Pneumococcal Vaccines</title>
            <description>Number of Participants with oral care and both an influenza vaccines (Flubik HA, 0.5ml, Mitsubishi Tanabe Pharm. Co.Ltd.) and a pneumococcal vaccine (PNEUMOVAX NP, 0.5ml, MSD Co.Ltd.) How to do oral care is the following;
1 dentist and 2 dental hygienists visited the nursing home once a week. After the residents agreed our receive oral care, the dentist/dental hygienist spent 15 minutes with brushing of teeth, scaling, oral wiping, gargling and cleaning of dentures, to reduce dental plaque which is oral bacteria mechanically by using cleaning tools, including toothbrush, interdental brush, dental scaler, tongue brush, and sponge brush to treatment of periodontal disease at the washstand in their private room. At the same time, we taught and recorded to the nursing care workers the methods of administering responsible oral care to dye for dental plaque by using plaque disclosing agent material.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="94"/>
                  <measurement group_id="O2" value="105"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Death From Pneumonia</title>
            <description>Number of participants for the death from pneumonia</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="8"/>
                  <measurement group_id="O2" value="1"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The results are expressed as means ± standard deviation (SD) or numbers (%). Differences between the 2 nursing homes were compared using Fisher’s test.</groups_desc>
            <non_inferiority>No</non_inferiority>
            <p_value>0.05</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Leaving Nursing Home</title>
        <description>Numer of resident for leaving nursing home</description>
        <time_frame>These participants were followed for the duration of nursing home stay, an average of 22 weeks.</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>These participants were determined as &quot;Not Completed&quot; due to &quot;Leaving nursing home&quot;. We excluded these participants from analysis for outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Leaving Nursing Home</title>
            <description>Numer of resident for leaving nursing home</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Leaving Nursing Home</title>
            <description>Numer of resident for leaving nursing home</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Reject Oral Care</title>
        <description>Number of resident to reject oral care</description>
        <time_frame>This participant rejected oral care before treatment, Day 1</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>This participant was determined as &quot;Not Completed&quot; due to &quot;Reject oral care&quot;. We excluded this participant from analysis for outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Reject Oral Care</title>
            <description>Number of resident to reject oral care</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="1"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Reject Oral Care</title>
            <description>Number of resident to reject oral care</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="1"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Reject Vaccine</title>
        <description>Number of resident to reject vaccine</description>
        <time_frame>These participants rejected vaccine before treatment, Day 1</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>These participants were determined as &quot;Not Completed&quot; due to &quot;Reject vaccine&quot;. We excluded these participants from analysis for outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Reject Vaccine</title>
            <description>Number of resident to reject vaccine</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="3"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Reject Vaccine</title>
            <description>Number of resident to reject vaccine</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="3"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Died Before Oral Care Starting</title>
        <description>Number of resident died before the start of oral care</description>
        <time_frame>This participant was died before treatment, Day 1</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>This participant was determined as &quot;Not Completed&quot; due to &quot;Died before oral care starting&quot;. We excluded this participant from analysis for outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Died Before Oral Care Starting</title>
            <description>Number of resident died before the start of oral care</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="1"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Died Before Oral Care Starting</title>
            <description>Number of resident died before the start of oral care</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="1"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <desc>Died in Period from pneumonia</desc>
      <group_list>
        <group group_id="E1">
          <title>Influenza Vaccine</title>
          <description>Number of Participants with only an influenza vaccine(Flubik HA, 0.5ml, Mitsubishi Tanabe Pharm. Co.Ltd.).</description>
        </group>
        <group group_id="E2">
          <title>Oral Care With Influenza and Pneumococcal Vaccines</title>
          <description>Number of Participants with oral care and both an influenza vaccines (Flubik HA, 0.5ml, Mitsubishi Tanabe Pharm. Co.Ltd.) and a pneumococcal vaccine (PNEUMOVAX NP, 0.5ml, MSD Co.Ltd.) How to do oral care is the following;
1 dentist and 2 dental hygienists visited the nursing home once a week. After the residents agreed our receive oral care, the dentist/dental hygienist spent 15 minutes with brushing of teeth, scaling, oral wiping, gargling and cleaning of dentures, to reduce dental plaque which is oral bacteria mechanically by using cleaning tools, including toothbrush, interdental brush, dental scaler, tongue brush, and sponge brush to treatment of periodontal disease at the washstand in their private room. At the same time, we taught and recorded to the nursing care workers the methods of administering responsible oral care to dye for dental plaque by using plaque disclosing agent material.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="94"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Died in period</sub_title>
                <description>9 (4.5%) of the 199 eligible participants were death from pneumonia still in period.</description>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="94"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Died before trial</sub_title>
                <description>One participant was died before trial.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="94"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="94"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>small numbers of subjects analyzed</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Masahiro Hatta</name_or_title>
      <organization>Department of Dentistry, Yubari Kibounomori, Japan</organization>
      <phone>+81-123-52-4339</phone>
      <email>masahiro.hatta@hotmail.co.jp</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
